COMPARISON OF EFFICACY AND SAFETY OF NATIVE EPTIFIBATIDE VS. TIROFIBAN IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION

• 来源期刊: 南京医科大学学报(英文版)
• 学科: 医学
• 年，卷（期）: 2008,（4）
• 页码范围: 238-242
• 页数: 5页
• 分类号: R5
• 语种: 英文

摘要

Objective: To compare clinical outcomes and safety of eptifibatide or tirofiban in patients with acute coronary syndrome(ACS) undergoing percutaneous coronary intervention(PCI). Methods:Thirty-six patients with ACS(unstable angina/non-ST-segment elevation myocardial infarction, UA/NSTEMI) who underwent PCI were randomly divided into two groups to receive eptifibatide or tirofiban treatment. Eptifibatide or tirofiban was predominantly initiated in the catheter laboratory before the intervention. In-hospital ...